DE69028603D1 - Arzneimittel für bessere gehirnwirkung - Google Patents

Arzneimittel für bessere gehirnwirkung

Info

Publication number
DE69028603D1
DE69028603D1 DE69028603T DE69028603T DE69028603D1 DE 69028603 D1 DE69028603 D1 DE 69028603D1 DE 69028603 T DE69028603 T DE 69028603T DE 69028603 T DE69028603 T DE 69028603T DE 69028603 D1 DE69028603 D1 DE 69028603D1
Authority
DE
Germany
Prior art keywords
those caused
medicines
cerebral
better brain
brain effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69028603T
Other languages
English (en)
Other versions
DE69028603T2 (de
Inventor
Y Daiichi Pharmaceut Shirasaki
Shinichiro Daiichi Phar Ashida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Santen Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd, Santen Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of DE69028603D1 publication Critical patent/DE69028603D1/de
Application granted granted Critical
Publication of DE69028603T2 publication Critical patent/DE69028603T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69028603T 1989-06-16 1990-06-14 Arzneimittel für bessere gehirnwirkung Expired - Fee Related DE69028603T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15364689 1989-06-16
PCT/JP1990/000773 WO1990015607A1 (fr) 1989-06-16 1990-06-14 Medicament pour l'ameliorations des fonctions cerebrales

Publications (2)

Publication Number Publication Date
DE69028603D1 true DE69028603D1 (de) 1996-10-24
DE69028603T2 DE69028603T2 (de) 1997-02-13

Family

ID=15567085

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69028603T Expired - Fee Related DE69028603T2 (de) 1989-06-16 1990-06-14 Arzneimittel für bessere gehirnwirkung

Country Status (8)

Country Link
US (1) US5182276A (de)
EP (1) EP0429676B1 (de)
KR (1) KR0133553B1 (de)
AT (1) ATE142881T1 (de)
CA (1) CA2032487A1 (de)
DE (1) DE69028603T2 (de)
DK (1) DK0429676T3 (de)
WO (1) WO1990015607A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015607A1 (fr) * 1989-06-16 1990-12-27 Santen Pharmaceutical Co., Ltd. Medicament pour l'ameliorations des fonctions cerebrales
EA019020B1 (ru) * 2011-07-12 2013-12-30 Институт Химических Проблем Им. М.Ф. Нагиева Национальной Академии Наук Азербайджана Способ лечения нарушений гемостаза при ушибах головного мозга
WO2024012554A1 (zh) * 2022-07-14 2024-01-18 上海日馨医药科技股份有限公司 Tpk激动剂及使用其治疗神经退行性疾病的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3166554A (en) * 1965-01-19 Certificate of correction
US3715353A (en) * 1970-10-12 1973-02-06 Squibb & Sons Inc (aminoalkoxy-benzylidene)-2h-benzothiazine-3(4h)-ones and related compounds
US3725403A (en) * 1970-10-20 1973-04-03 Squibb & Sons Inc Benzothiazine derivatives
JPS5651465A (en) * 1979-10-02 1981-05-09 Yoshitomi Pharmaceut Ind Ltd Benzothiazine derivative
JPS59148771A (ja) * 1983-02-09 1984-08-25 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
DE3347173A1 (de) * 1983-12-27 1985-07-04 Hoechst Ag, 6230 Frankfurt Neue benzothiazin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
JPS60166674A (ja) * 1984-02-09 1985-08-29 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
EP0186310A1 (de) * 1984-11-28 1986-07-02 Takeda Chemical Industries, Ltd. 1,4-Benzothiazinderivate, deren Herstellung und Verwendung
JPH0625186B2 (ja) * 1985-03-19 1994-04-06 参天製薬株式会社 ２−アリ−ルベンゾチアジン誘導体
EP0237573B1 (de) * 1985-07-29 1992-01-15 Santen Pharmaceutical Co., Ltd. Neue benzothiazinabkömmlinge
US4654372A (en) * 1986-01-10 1987-03-31 Warner-Lambert Company Method for using verapamil for treating stroke
DE3614355A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag Neue benzothiazinon-derivate, verfahren zu ihrer herstellung , sie enthaltende arzneimittel und deren verwendung
DE3614363A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag Benzothiazinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
JPS6357578A (ja) * 1986-08-27 1988-03-12 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
JPH068284B2 (ja) * 1986-08-27 1994-02-02 参天製薬株式会社 ３−チオキソ−ベンゾチアジン誘導体
JPS63104969A (ja) * 1986-10-23 1988-05-10 Santen Pharmaceut Co Ltd 含硫黄複素環化合物
WO1990015607A1 (fr) * 1989-06-16 1990-12-27 Santen Pharmaceutical Co., Ltd. Medicament pour l'ameliorations des fonctions cerebrales

Also Published As

Publication number Publication date
EP0429676B1 (de) 1996-09-18
KR920700645A (ko) 1992-08-10
CA2032487A1 (en) 1990-12-17
DE69028603T2 (de) 1997-02-13
EP0429676A4 (en) 1992-05-20
ATE142881T1 (de) 1996-10-15
US5182276A (en) 1993-01-26
WO1990015607A1 (fr) 1990-12-27
EP0429676A1 (de) 1991-06-05
KR0133553B1 (ko) 1998-04-23
DK0429676T3 (de) 1997-03-10

Similar Documents

Publication Publication Date Title
NO20025517D0 (no) Triazolderivater
ATE227343T1 (de) Protease und verwandte dns-verbindungen
DE69429527T2 (de) Inhibitoren von beta-amyloid-protein-herstellung
ES2160124T3 (es) Utilizacion de bcl-2 para la fabricacion de medicamentos para el tratamiento terapeutico y la prevencion de enfermedades.
DE69213814T2 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
ATE222763T1 (de) Verwendung von imidazo-(1,2-a)-pyridin-3-acetamid-derivaten für die therapeutische behandlung von neuropsychiatrischen syndromen in zusammenhang mit störungen der nervenbahnen der basalganglien
DE69807587D1 (de) Quinazolin-4-on AMPA Antagonisten
ATE526981T1 (de) Verwendung von vegf 165 und homologen zur behandlung von neurologischen störungen
ES2100851T3 (es) Acidos quinolincarboxilicos sustituidos.
DE69028603T2 (de) Arzneimittel für bessere gehirnwirkung
DE68925004T2 (de) Verwendung von 2,3,4,5-Tetrahydro-1H-3-Benzazepinen bei der Behandlung von neurologischen Störungen.
DE69320349D1 (de) Verwendung von guanosin zur herstellung von arzneimitteln zur behandlung von zerebralen funktionsstörungen
DE69830450D1 (de) Neue Atropisomere von 2,3-Disubstituierten-(5,6)-heteroarylkondensierten-pyrimidin-4-onen
MX9200948A (es) Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos.
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
DE69836830D1 (de) Verwendung von proteinen der midkine-familie in der behandlung von ischämischen krankheiten
ES2069528T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso en el tratamiento de trastornos neurodegenerativos.
NO883605L (no) Optiske isomerer av et spiroquinuklidinderivat.
ATE99307T1 (de) Substituierte chromane und verwandte verbindungen fuer die behandlung von asthma.
DE68909304D1 (de) Aminosäuren für der Behandung neurodegenerativer Störungen.
EP0677293A4 (de) Pharmazeutische verwendung eines terpyridinderivates.
HU9201247D0 (en) Process for the production of condensed diazepinone derivatives and of mnedical preparations containing them as active agents
ES2096035T3 (es) Compuestos y procedimientos para el tratamiento de trastornos tromboembolicos.
FI93448C (fi) Menetelmä terapeuttisesti käyttökelpoisen triatsolo/4,5-c/pyridiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee